This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Xiaodong Wang: Innovator in Dipeptidyl Peptidase Inhibitors
Introduction
Xiaodong Wang is a prominent inventor based in Superior, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit dipeptidyl peptidase. His innovative work has led to the creation of valuable therapeutic options for various medical conditions.
Latest Patents
Xiaodong Wang holds 1 patent related to dipeptidyl peptidase inhibitors. His patent, titled "Dipeptidyl peptidase inhibitors - Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV inhibitors comprising Formulae: where the substituents are as described herein," showcases his expertise in this specialized area of research.
Career Highlights
Wang is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His role at Takeda allows him to further his research and development efforts in creating innovative pharmaceutical solutions.
Collaborations
Throughout his career, Xiaodong Wang has collaborated with notable colleagues, including Stephen L. Gwaltney and Jeffrey Alan Stafford. These collaborations have contributed to the advancement of research in the field of pharmaceuticals.
Conclusion
Xiaodong Wang's contributions to the development of dipeptidyl peptidase inhibitors highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic options that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile